Biosyent Inc logo

Biosyent Inc

C$ 7.50 (+2.18%) Oct 4
P/E:
14.94
P/B:
2.83
Market Cap:
C$ 91.40M ($ 67.18M)
Enterprise V:
C$ 64.98M ($ 47.76M)
Volume:
12.10K
Avg Vol (2M):
5.67K
Also Trade In:
Volume:
12.10K
Market Cap C$:
91.40M
Market Cap $:
67.18M
PE Ratio:
14.94
Avg Vol (2-Month):
5.67K
Enterprise Value C$:
64.98M
Enterprise Value $:
47.76M
PB Ratio:
2.83
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Biosyent Inc is a growth-oriented specialty pharmaceutical company focused on in-licensing or acquiring innovative pharmaceutical and other healthcare products. Its products include FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Repagyn and Tibella.
Name Current Vs Industry Vs History
Cash-To-Debt 18.88
Equity-to-Asset 0.86
Debt-to-Equity 0.05
Debt-to-EBITDA 0.16
Interest Coverage 100.05
Piotroski F-Score 7/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 14.18
Distress
Grey
Safe
Beneish M-Score -2.41
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 33.71
9-Day RSI 34.75
14-Day RSI 37.09
6-1 Month Momentum % -16.04
12-1 Month Momentum % 9.18

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 9.29
Quick Ratio 8.55
Cash Ratio 7.47
Days Inventory 165.67
Days Sales Outstanding 42.3
Days Payable 244.86

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio 4.5

Financials

TSXV:RX's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil C$) 27.581
EPS (TTM) (C$) 0.502
Beta 1.15
Volatility % 28.59
14-Day RSI 37.09
14-Day ATR (C$) 0.199907
20-Day SMA (C$) 7.8535
12-1 Month Momentum % 9.18
52-Week Range (C$) 6.76 - 10
Shares Outstanding (Mil) 12.19

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Biosyent Inc Filings

Document Form Filing Date
No Filing Data

Biosyent Inc Analysis

Share your research